Pal S, Cheng X, Peterson E M, de la Maza L M
Department of Pathology, University of California, Irvine 92717-4800.
J Gen Microbiol. 1993 Jul;139(7):1565-70. doi: 10.1099/00221287-139-7-1565.
A B-cell epitope, AEFPLDIT, was located to the variable sequent 3 of the major outer-membrane protein (MOMP) using the monoclonal antibody L3-1, raised to the Chlamydia trachomatis serovar L3 MOMP. By Western blot and inclusion immunofluorescence assay the monoclonal antibody recognized all the C complex and C-related complex serovars of C. trachomatis, except serovar C. Dot-blot and ELISA data using native elementary bodies indicated that the epitope was surface exposed. The monoclonal antibody, at concentrations of 10 and 100 micrograms per 10(7) chlamydial inclusion-forming units, was able to neutralize the infectivity of chlamydia in an in vivo assay but did not neutralize chlamydia in vitro or in a mouse toxicity assay. A peptide corresponding to the variable sequent 3 has previously been shown to also elicit a T-cell response; thus, careful consideration should be given to inclusion of this region of the major outer-membrane protein in a subunit vaccine.
利用针对沙眼衣原体血清型L3主要外膜蛋白(MOMP)产生的单克隆抗体L3-1,将一个B细胞表位AEFPLDIT定位到主要外膜蛋白可变序列3上。通过蛋白质印迹法和包涵体免疫荧光试验,该单克隆抗体识别除血清型C外的所有沙眼衣原体C复合物及C相关复合物血清型。使用天然原体的斑点印迹法和酶联免疫吸附测定数据表明该表位暴露于表面。在体内试验中,每10⁷衣原体包涵体形成单位中浓度为10微克和100微克的单克隆抗体能够中和衣原体的感染性,但在体外试验或小鼠毒性试验中不能中和衣原体。先前已表明,与可变序列3对应的肽也能引发T细胞反应;因此,在亚单位疫苗中纳入主要外膜蛋白的这一区域时应谨慎考虑。